by Jessica Etheridge | Aug 27, 2024 | Company Details, News and Events
August 26, 2024 | Tom Ballard It’s been a whirlwind year for New Day Diagnostics While seeing its cancer diagnostic work to fruition, the future is becoming a national leader in clinical trial management along with contract research. The last 12 months or so for the...
by Jessica Etheridge | Sep 14, 2023 | Company Details, News and Events
KNOXVILLE, Tenn., September 14, 2023–New Day Diagnostics is pleased to announce that the Extraordinary General Meeting of Epigenomics AG (Frankfurt General Standard: ECX1), a molecular diagnostics company focused on blood testing for the early detection of...
by Jessica Etheridge | Jul 24, 2023 | Company Details, News and Events
New Day Diagnostics LLC is pleased to announce that it has entered into an asset purchase agreement with Epigenomics AG (Frankfurt Prime Standard: ECX, OTCQX: EPGNY), a molecular diagnostics company focused on blood testing for the early detection of cancer. This...
by Jessica Etheridge | Jul 5, 2023 | Company Details, News and Events
KNOXVILLE, Tenn. & BOCA RATON, Fla.–(BUSINESS WIRE)–EDP Biotech Corp. (EDP Biotech) and New Day Diagnostics, LLC (New Day Diagnostics) are pleased to announce their combination, forming a vertically integrated force in the expedited development and...
by Jessica Etheridge | Jan 12, 2023 | Company Details, News and Events
Sam Libby joins EDP Biotech Corporation as Head of Mergers & Acquisitions and Corporate Development to expand investments and create new corporate relationship opportunities as the company grows. KNOXVILLE, Tenn., January 12, 2023–(BUSINESS WIRE)–EDP...
by Jessica Etheridge | Aug 18, 2021 | News and Events
By Abby Kousouris Published: Aug. 17, 2021 at 7:25 PM EDT KNOXVILLE, Tenn. (WVLT) – A local Knoxville company says they’re seeing more demand for COVID-19 testing. EDP Biotech Corporation has different options available for people who want to find out if they...
